Login / Signup

Inhibition of Lipid Accumulation and Oxidation in Hepatocytes by Bioactive Bean Extracts.

Dya Fita DibweEmi KitayamaSaki ObaNire TakeishiHitoshi ChibaShu-Ping Hui
Published in: Antioxidants (Basel, Switzerland) (2024)
During our search for natural resources that can inhibit lipid droplet accumulation (LDA) and potentially prevent metabolic dysfunction-associated fatty liver disease (MAFLD) and its progressive stages, such as metabolic dysfunction-associated steatohepatitis (MASH), eight bean extracts (BE1-BE8) were tested for their ability to inhibit lipid accumulation and oxidation in hepatocytes. Substantial inhibitory effects on LDA with bean extracts (BEs) BE2, BE4, BE5, and BE8 were demonstrated. An advanced lipidomic approach was used to quantify the accumulation and inhibition of intracellular triacylglycerol (TAG) and its oxidized species, TAG hydroperoxide (TGOOH), in hepatocytes under fatty acid-loading conditions. The results show that the antioxidants BE2 and BE8 are potential candidates for regulating TAG and TGOOH accumulation in fatty acid-induced lipid droplets (LDs). This study suggests that bean-based foods inhibit LDs formation by decreasing intracellular lipids and lipid hydroperoxides in the hepatocytes. The metabolic profiling of BEs revealed that BE2 and BE8 contained polyphenolic compounds. These may be potential resources for the development of functional foods and drug discovery targeting MAFLD/MASH.
Keyphrases
  • fatty acid
  • drug discovery
  • liver injury
  • single cell
  • drug induced
  • oxidative stress
  • reactive oxygen species
  • hydrogen peroxide
  • drug delivery
  • visible light